Menczer J - Search Results

1

Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer.

Levy T, Inbar M, Menczer J, Grisaru D, Glezerman M, Safra T. Levy T, et al. Among authors: menczer j. Gynecol Oncol. 2004 Dec;95(3):686-90. doi: 10.1016/j.ygyno.2004.09.005. Gynecol Oncol. 2004. PMID: 15581982 Clinical Trial.

2

The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patients.

Levy T, Weiser R, Boaz M, Ben Shem E, Golan A, Menczer J. Levy T, et al. Among authors: menczer j. Gynecol Oncol. 2013 Apr;129(1):165-8. doi: 10.1016/j.ygyno.2012.12.024. Epub 2012 Dec 27. Gynecol Oncol. 2013. PMID: 23274778

3

Expression of c-kit in uterine carcinosarcoma.

Menczer J, Kravtsov V, Levy T, Berger E, Glezerman M, Avinoach I. Menczer J, et al. Gynecol Oncol. 2005 Jan;96(1):210-5. doi: 10.1016/j.ygyno.2004.09.045. Gynecol Oncol. 2005. PMID: 15589603

4

A comparison between different postoperative treatment modalities of uterine carcinosarcoma.

Menczer J, Levy T, Piura B, Chetrit A, Altaras M, Meirovitz M, Glezerman M, Fishman A. Menczer J, et al. Gynecol Oncol. 2005 Apr;97(1):166-70. doi: 10.1016/j.ygyno.2004.12.006. Gynecol Oncol. 2005. PMID: 15790453

5

Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels.

Menczer J, Chetrit A, Sadetzki S, Golan A, Levy T. Menczer J, et al. Gynecol Oncol. 2006 Oct;103(1):137-40. doi: 10.1016/j.ygyno.2006.02.005. Epub 2006 Mar 27. Gynecol Oncol. 2006. PMID: 16564077

6

Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patients.

Safra T, Ron I, Boaz M, Brenner J, Grisaru D, Inbar M, Hayat H, Menczer J, Golan A, Levy T. Safra T, et al. Among authors: menczer j. Acta Oncol. 2006;45(4):463-8. doi: 10.1080/02841860500509035. Acta Oncol. 2006. PMID: 16760183

7

Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer.

Safra T, Menczer J, Bernstein R, Shpigel S, Inbar MJ, Grisaru D, Golan A, Levy T. Safra T, et al. Among authors: menczer j. Gynecol Oncol. 2007 Apr;105(1):205-10. doi: 10.1016/j.ygyno.2006.11.017. Epub 2007 Jan 18. Gynecol Oncol. 2007. PMID: 17239430 Clinical Trial.

8

Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.

Safra T, Menczer J, Bernstein RM, Shpigel S, Matcejevsky D, Inbar MJ, Golan A, Grisaru D, Levy T. Safra T, et al. Among authors: menczer j. Gynecol Oncol. 2009 Aug;114(2):215-8. doi: 10.1016/j.ygyno.2009.04.008. Epub 2009 May 14. Gynecol Oncol. 2009. PMID: 19446318 Clinical Trial.

9

Platin sensitivity and long-term survival in Stage III epithelial ovarian cancer patients.

Menczer J, Golan A, Levy T. Menczer J, et al. Eur J Gynaecol Oncol. 2008;29(5):473-5. Eur J Gynaecol Oncol. 2008. PMID: 19051815

10

Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?

Menczer J, Usviatzov I, Ben-Shem E, Golan A, Levy T. Menczer J, et al. J Gynecol Oncol. 2011 Sep;22(3):183-7. doi: 10.3802/jgo.2011.22.3.183. Epub 2011 Sep 28. J Gynecol Oncol. 2011. PMID: 21998761 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters